Peloton has opportunities to completely transform established treatment paradigms and improve patient outcomes in kidney cancer, VHL Disease, and other serious diseases.

ABOUT US

Leadership

Board of Directors

Scientific Advisory Board

Investors

OUR SCIENCE

HIF-2α

CD73

Ubiquitin Ligase

PIPELINE

HIF-2α Development Program

Clinical Trials

Publications

Expanded Access Policy

NEWSROOM

Archives 2017

Archives 2016

Media Contact

CONTACT

Business Development

Privacy

CAREERS

Job Listings

Dallas Life

San Francisco Life

2330 Inwood Rd Suite 226,
Dallas, TX 75235

+1 (972) 629-4100

 

580 California St  Suite 1658, 16th Floor
San Francisco, CA  94104

© 2019 Peloton Therapeutics, Inc. All rights reserved.

Legal  |  Cookies